SEC Form 4 · accession 0001179110-16-031848
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Oyler
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to buy)F2,F1 | $2.84 | Nov 16, 2016 | A | 2,047,500 | A | — | Nov 15, 2026 | Ordinary Shares | 2,047,500 | 2,047,500 | D |
Explanation of responses
- F1These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares subject to this option are subject to accelerated vesting upon a change in control or certain termination events.
- F2In ordinary shares. One American Depositary Share represents 13 ordinary shares.